Sanofi Consumer Healthcare Intrinsic Value
SANOFICONR Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2081.20 | ₹1664.96 - ₹2497.44 | -53.4% | EPS: ₹94.60, Sector P/E: 22x |
| Book Value Method | asset | ₹892.82 | ₹803.54 - ₹982.10 | -80.0% | Book Value/Share: ₹118.70, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1339.23 | ₹1205.31 - ₹1473.15 | -70.0% | Revenue/Share: ₹358.26, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1785.64 | ₹1607.08 - ₹1964.20 | -60.0% | EBITDA: ₹304.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹1339.23 | ₹1205.31 - ₹1473.15 | -70.0% | EPS Growth: 14.9%, Fair P/E: 12.0x |
| Growth Adjusted P/E | growth | ₹1525.42 | ₹1372.88 - ₹1677.96 | -65.8% | Revenue Growth: 15.0%, Adj P/E: 16.1x |
| ROE Based Valuation | profitability | ₹2232.05 | ₹2008.85 - ₹2455.26 | -50.0% | ROE: 79.9%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1339.23 | ₹1205.31 - ₹1473.15 | -70.0% | EPS: ₹94.60, BVPS: ₹118.70 |
Want to compare with current market value? Check SANOFICONR share price latest .
Valuation Comparison Chart
SANOFICONR Intrinsic Value Analysis
What is the intrinsic value of SANOFICONR?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sanofi Consumer Healthcare (SANOFICONR) is ₹1525.42 (median value). With the current market price of ₹4464.10, this represents a -65.8% variance from our estimated fair value.
The valuation range spans from ₹892.82 to ₹2232.05, indicating ₹892.82 - ₹2232.05.
Is SANOFICONR undervalued or overvalued?
Based on our multi-method analysis, Sanofi Consumer Healthcare (SANOFICONR) appears to be trading above calculated value by approximately 65.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 14.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.58 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 79.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 35.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.91x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Sanofi Consumer Healthcare
Additional stock information and data for SANOFICONR
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹439 Cr | ₹439 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |